| Novartis Pharma Schweiz AG - Enerzair Breezhaler 150/50/160 μg, Hartkapsel mit Pulver zur Inhalation | | 67596 | | 02 | | Enerzair Breezhaler 150/50/160 μg | | Hartkapsel mit Pulver zur Inhalation | | R03AL12 | | Indacaterol, Glycopyrronium Bromide and Mometasone | | 24.09.2020 | | |
| | Composition | | indacaterolum 150 µg ut indacateroli acetas, glycopyrronium 50 µg ut glycopyrronii bromidum, mometasoni furoas 160 µg, lactosum monohydricum 24..567 mg, magnesii stearas, Kapselhülle: hypromellosum, carrageenanum, kalii chloridum, E 172 (flavum), E 132, aqua purificata, cera carnauba, Drucktinte: aqua purificata, E 172 (nigrum), alcohol isopropylicus, propylenglycolum, hypromellosum pro capsula. | | Packungsbestandteile | | | |
|
